It was reported through a research article that 28 patients were had an endovascular repair of the popliteal artery aneurysms (paas) with a supera stent.Twenty-three patients paas were asymptomatic and 6 presented with symptoms.It was noted in all cases a.018 steelcore guide wire was used for insertion and deployment of the stent with no issue and the preclose porgilde was used in two cases with no issue.During the 28 cases there were no issues during the procedure; however, once one case did require surgical correction 5 days later of the pseudoaneurysm that developed at a common femoral artery at the site of percutaneous access.It was noted the complication occurred after manual compression; therefore, prolonging the hospital stay.Other complications that arose after the 6 month follow up was in two cases aneurysm thrombosis occurred, while at the 12 month follow up a total of 10 patients.The diameter of the aneurysm remained stable in all other cases, with a 100% freedom from sac enlargement.One death was noted; however, it was revealed the death was not related to the aneurysm or the procedure it was due to ovarian cancer.For endovascular repair of paas, the use of a thick interwoven-wire stent showed encouraging mid-term results with no cases of stent fractures, occlusion or aneurysm increase.Specific patient information is documented as unknown.Details are listed in the attached article, titled "outcome of endovascular repair of popliteal artery aneurysms using the supera stent." no additional information was provided.
|
B3, b6, d6a: dates estimated.D4: the udi is unknown due to the part/lot number was not provided.The device was not returned for evaluation.A review of the lot history record of the reported lot could not be conducted because the part and lot number was not provided.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The treatment appears to be related to the operational context of the procedure.The reported patient effects of thrombosis and pseudoaneurysm are listed in the supera peripherial stent system instructions for use as potential adverse effects of peripheral percutaneous intervention.There is no indication of a product quality issue with respect to manufacture, design or labeling.Literature attachment: article title: outcome of endovascular repair of popliteal artery aneurysms using the supera stent.
|